Laurence Reid is SVP & Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have made 3 open-market trades across 3 companies since 2012, most recently 2026-09-09.
CIK 0001492749
3 open-market purchases totalling $110K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALNY | 18,103 | $4.2M |
| DBTX | 220,849 | $1.1M |
| MGX | 20,000 | $16K |
| Total | $5.3M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MGX | BUY | 2026-09-09 | 2026-09-11 | $1.17 | $23K | -4.6% | -14.3% | — |
| DBTX | BUY | 2021-09-15 | 2021-09-17 | $7.64 | $76K | -8.4% | -13.8% | -43.1% |
| ALNY | SELL · 10b5-1 | 2014-11-18 | 2014-11-19 | $90.67 | $907K | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2014-08-18 | 2014-08-20 | $67.33 | $909K | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2014-05-19 | 2014-05-21 | $57.83 | $781K | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2014-02-19 | 2014-02-20 | $80.06 | $1.6M | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2013-11-13 | 2013-11-15 | $53.36 | $720K | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2013-05-28 | 2013-05-30 | $30.00 | $150K | -18.4% | +0.9% | +0.9% |
| ALNY | SELL · 10b5-1 | 2013-02-08 | 2013-02-12 | $25.00 | $125K | -18.4% | +0.9% | +0.9% |
| ALNY | BUY | 2012-02-21 | 2012-02-23 | $10.75 | $10K | -18.4% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.